12 Campus Blvd, Newtown Square, PA 19073, USA
(610) 325-9814
(610) 325-9823

 PPXRD-14 Presentations

June 2016 – Fort Myers, Florida, U.S.A.

PPXRD-14 Workshop presentations

Presentation Title Authors
‣ QPA of crystalline and amorphous phase abundance with XRPD techniques: bases and methods
‣ Synchrotron XRPD
F. Gozzo, Excelsus Structural Solutions (Swiss) AG, Switzerland and Excelsus Structural Solutions SPRL, Belgium
‣ Practical assessment of merits of methods for QPA A. Kern, Bruker AXS GmbH, Karlsruhe, Germany
‣ Issues in QPA – minimising systematic errors A. Kern, Bruker AXS GmbH, Karlsruhe, Germany
‣ Challenges of absolute quantification of pharmaceuticals by the internal standard methods M. Reinle-Schmitt, Swiss Light Source, Paul Scherrer Institute, Villigen, Switzerland
‣ Instrumentation and sample presentation: Laboratory & Synchrotron A. Kern, Bruker AXS GmbH, Karlsruhe, Germany,
F. Gozzo, Excelsus Structural Solutions SPRL, Brussels, Belgium

PPXRD-14 Session presentations

Presentation Title Authors
‣ Invited – Instrumentation and Applications of 2D XRD for Pharmaceutics B.B. He, Bruker AXS, Madison, WI, U.S.A.
‣ Large-Area CdTe Pixel Detectors for High-Energy X-ray Diffraction Applications D. Sisak Jung, T. Donath, DECTRIS Ltd., Switzerland
J. Bednarcik, Deutsches Elektronen-Synchrotron, Germany
M. Di Michiel, European Synchrotron Radiation Facility, France
S. Jacques, School of Materials, University of Manchester, UK
‣ Crystal Structure Determination from Beam Sensitive Organic Materials using Electron Diffraction P.P. Das, S. Nikolopoulos, NanoMEGAS SPRL, Brussels, Belgium
‣ Invited – Using X-ray Powder Diffraction and Other Solid-State Data to Protect Pharmaceutical Inventions E.H. Barash, Barash Law LLC, Lafayette, IN, U.S.A.
‣ Humidity Induced Phase Transitions in HEWLYSOZYME Investigated By Microcrystalline Powder Diffraction D. Beckers, T. Degen, G. Nénert, PANalytical B.V., Almelo, The Netherlands
S. Saslis, S. Logotheti, F. Karavassili, A. Valmas, I. Margiolaki, University of Patras, Greece
S. Trampari, Kapodistrian University of Athens, Greece
‣ Invited – Strategies to Expand Solid-state Landscapes of Drugs to Enable Successful Tablet Formulation Development C. Sun, Department of Pharmaceutics, University of Minnesota, Minneapolis, MN, U.S.A.
‣ Invited – Two-Dimensional X-ray Diffractometry in Pharmaceutical Product and Process Development N.K. Thakral, Amgen Inc., Thousand Oaks, CA, U.S.A.
‣ Invited – Capturing the Significance of X-ray Crystallography in Pharmaceutical Field: The Application to Characterize New Salt, Co-Crystal and Co-Amorphous E. Yonemochi, Hoshi University, Tokyo, Japan
‣ The Analysis of Non-Crystalline Materials in Pharmaceutical Formulations T.G. Fawcett, S.N. Kabekkodu, S. Gates-Rector, A.M. Gindhart, J.R. Blanton, T.N. Blanton, ICDD, Newtown Square, PA, U.S.A.
‣ ICDD Powder Diffraction File Coverage of Polymers Used in Pharmaceutical and Biomedical Applications T.N. Blanton, ICDD, Newtown Square, PA, U.S.A.
‣ Absolute Quantification of Pharmaceuticals: The Search of Suitable Internal Standards M.L. Reinle-Schmitt, Swiss Light Source, Paul Scherrer Institute, Villigen, Switzerland
P.P. Mazzeo, Excelsus Structural Solutions (Swiss) AG, Switzerland
A. Prodi, Excelsus Structural Solutions SPRL, Belgium
F. Gozzo, Excelsus Structural Solutions (Swiss) AG, Switzerland and Excelsus Structural Solutions SPRL, Belgium
‣ Excipient Reference Data in the Powder Diffraction File™ (PDF®) for Phase Identification in Pharmaceutical Formulations J. Quagliarello, K. Krishnan, S. Gates-Rector, T.G. Fawcett, T.N. Blanton, ICDD, Newtown Square, PA, U.S.A.